2,024
Views
28
CrossRef citations to date
0
Altmetric
Original Research

Neoadjuvant immunotherapy with chitosan and interleukin-12 to control breast cancer metastasis

, , , , , & show all
Article: e968001 | Received 15 Aug 2014, Accepted 17 Sep 2014, Published online: 26 Nov 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Sean G. Smith, John L. Baltz, Bhanu Prasanth Koppolu, Sruthi Ravindranathan, Khue Nguyen & David A. Zaharoff. (2017) Immunological mechanisms of intravesical chitosan/interleukin-12 immunotherapy against murine bladder cancer. OncoImmunology 6:1.
Read now

Articles from other publishers (27)

Shengfeng Yang, Dacheng Li, Weili Liu & Xiaolin Chen. (2023) Polysaccharides from marine biological resources and their anticancer activity on breast cancer. RSC Medicinal Chemistry 14:6, pages 1049-1059.
Crossref
Gemalene M. Sunga, Jeffrey HartgerinkAndrew G. SikoraSimon Young. (2023) Enhancement of Immunotherapies in Head and Neck Cancers Using Biomaterial-Based Treatment Strategies. Tissue Engineering Part C: Methods 29:6, pages 257-275.
Crossref
Maura R. Vrabel, Jacob A. Schulman, Francis B. Gillam, Siena M. Mantooth, Khue G. Nguyen & David A. Zaharoff. (2023) Focal Cryo-Immunotherapy with Intratumoral IL-12 Prevents Recurrence of Large Murine Tumors. Cancers 15:8, pages 2210.
Crossref
Antonio E. Barberio, Sean G. Smith, Ivan S. Pires, Sonia Iyer, Ferenc Reinhardt, Mariane B. Melo, Heikyung Suh, Robert A. Weinberg, Darrell J. Irvine & Paula T. Hammond. (2022) Layer‐by‐layer interleukin‐12 nanoparticles drive a safe and effective response in ovarian tumors . Bioengineering & Translational Medicine 8:2.
Crossref
Nouf Alluqmani, Anna Jirovec, Zaid Taha, Oliver Varette, Andrew Chen, Daniel Serrano, Glib Maznyi, Sarwat Khan, Nicole E. Forbes, Rozanne Arulanandam, Rebecca C. Auer & Jean-Simon Diallo. (2022) Vanadyl sulfate-enhanced oncolytic virus immunotherapy mediates the antitumor immune response by upregulating the secretion of pro-inflammatory cytokines and chemokines. Frontiers in Immunology 13.
Crossref
Jeaneen Venkatas & Moganavelli Singh. (2022) Localized Nano-mediated Interleukin-12 Gene Therapy: Promising Candidate for Cancer Immunotherapeutics. Current Cancer Drug Targets 22:10, pages 825-842.
Crossref
Tiara S. Napier, Chanelle L. Hunter, Patrick N. Song, Benjamin M. Larimer & Anna G. Sorace. (2022) Preclinical PET Imaging of Granzyme B Shows Promotion of Immunological Response Following Combination Paclitaxel and Immune Checkpoint Inhibition in Triple Negative Breast Cancer. Pharmaceutics 14:2, pages 440.
Crossref
Vijay Sagar Madamsetty, Shima Tavakol, Saeid Moghassemi, Arezoo Dadashzadeh, John D. Schneible, Iman Fatemi, Abdolsamad Shirvani, Ali Zarrabi, Fereshteh Azedi, Ali Dehshahri, Abbas Aghaei Afshar, Kian Aghaabbasi, Abbas Pardakhty, Reza Mohammadinejad & Prashant Kesharwani. (2022) Chitosan: A versatile bio-platform for breast cancer theranostics. Journal of Controlled Release 341, pages 733-752.
Crossref
Md Salman Shakil, Kazi Mustafa Mahmud, Mohammad Sayem, Mahruba Sultana Niloy, Sajal Kumar Halder, Md. Sakib Hossen, Md. Forhad Uddin & Md. Ashraful Hasan. (2021) Using Chitosan or Chitosan Derivatives in Cancer Therapy. Polysaccharides 2:4, pages 795-816.
Crossref
Sanaz Sheikhzadeh, Nowruz Delirezh & Rahim Hobbenaghi. (2021) Mannosylated polylactic-co-glycolic acid (MN-PLGA) nanoparticles induce potent anti-tumor immunity in murine model of breast cancer. Biomedicine & Pharmacotherapy 142, pages 111962.
Crossref
Mohamed Labib Salem, Samar Salman & Ibrahim O. Barnawi. (2021) Brief in vitro IL-12 conditioning of CD8 + T Cells for anticancer adoptive T cell therapy. Cancer Immunology, Immunotherapy 70:10, pages 2751-2759.
Crossref
Yue Sun, Jiayu Yang, Tong Yang, Yifan Li, Rongyue Zhu, Yanhui Hou & Yanhua Liu. (2021) Co-delivery of IL-12 cytokine gene and cisplatin prodrug by a polymetformin-conjugated nanosystem for lung cancer chemo-gene treatment through chemotherapy sensitization and tumor microenvironment modulation. Acta Biomaterialia 128, pages 447-461.
Crossref
Jeaneen Venkatas & Moganavelli Singh. (2021) Nanomedicine-mediated optimization of immunotherapeutic approaches in cervical cancer. Nanomedicine 16:15, pages 1311-1328.
Crossref
Beatriz V. Lima, Maria J. Oliveira, Mário A. Barbosa, Raquel M. Gonçalves & Flávia Castro. (2021) Immunomodulatory potential of chitosan-based materials for cancer therapy: a systematic review of in vitro , in vivo and clinical studies . Biomaterials Science 9:9, pages 3209-3227.
Crossref
Georgia Koutsoumpli, Oana Draghiciu, Hans W Nijman, Cesar Oyarce & Toos Daemen. 2021. Cancer Immunology. Cancer Immunology 61 83 .
Khue G. Nguyen, Maura R. Vrabel, Siena M. Mantooth, Jared J. Hopkins, Ethan S. Wagner, Taylor A. Gabaldon & David A. Zaharoff. (2020) Localized Interleukin-12 for Cancer Immunotherapy. Frontiers in Immunology 11.
Crossref
Yue Sun, Lu Liu, Liyue Zhou, Shuangyu Yu, Yang Lan, Qiangwei Liang, Jinxia Liu, Aichen Cao & Yanhua Liu. (2020) Tumor Microenvironment-Triggered Charge Reversal Polymetformin-Based Nanosystem Co-Delivered Doxorubicin and IL-12 Cytokine Gene for Chemo–Gene Combination Therapy on Metastatic Breast Cancer. ACS Applied Materials & Interfaces 12:41, pages 45873-45890.
Crossref
Antonio E. Barberio, Sean G. Smith, Santiago Correa, Cathy Nguyen, Bang Nhan, Mariane Melo, Talar Tokatlian, Heikyung Suh, Darrell J. Irvine & Paula T. Hammond. (2020) Cancer Cell Coating Nanoparticles for Optimal Tumor-Specific Cytokine Delivery. ACS Nano 14:9, pages 11238-11253.
Crossref
Jieyu Li, Wansong Lin, Huijing Chen, Zhiping Xu, Yunbin Ye & Mingshui Chen. (2020) Dual-target IL-12-containing nanoparticles enhance T cell functions for cancer immunotherapy. Cellular Immunology 349, pages 104042.
Crossref
Noor Momin, Naveen K. Mehta, Nitasha R. Bennett, Leyuan Ma, Joseph R. Palmeri, Magnolia M. Chinn, Emi A. Lutz, Byong Kang, Darrell J. Irvine, Stefani Spranger & K. Dane Wittrup. (2019) Anchoring of intratumorally administered cytokines to collagen safely potentiates systemic cancer immunotherapy. Science Translational Medicine 11:498.
Crossref
James L. Gulley, Elizabeth A. Repasky, Laura S. Wood & Lisa H. Butterfield. (2017) Highlights of the 31st annual meeting of the Society for Immunotherapy of Cancer (SITC), 2016. Journal for ImmunoTherapy of Cancer 5:1.
Crossref
Camila S. Padilha, Poliana Camila Marinello, Daniel A. Galvão, Robert U. Newton, Fernando H. Borges, Fernando Frajacomo & Rafael Deminice. (2017) Evaluation of resistance training to improve muscular strength and body composition in cancer patients undergoing neoadjuvant and adjuvant therapy: a meta-analysis. Journal of Cancer Survivorship 11:3, pages 339-349.
Crossref
Lauren Milling, Yuan Zhang & Darrell J. Irvine. (2017) Delivering safer immunotherapies for cancer. Advanced Drug Delivery Reviews 114, pages 79-101.
Crossref
Sruthi Ravindranathan, Bhanu Koppolu, Sean Smith & David Zaharoff. (2016) Effect of Chitosan Properties on Immunoreactivity. Marine Drugs 14:5, pages 91.
Crossref
Joshua M. Gammon, Neil M. Dold & Christopher M. Jewell. (2016) Improving the clinical impact of biomaterials in cancer immunotherapy. Oncotarget 7:13, pages 15421-15443.
Crossref
Witold Lasek & Radoslaw ZagozdzonWitold Lasek & Marek Jakóbisiak. 2016. Interleukin 12: Antitumor Activity and Immunotherapeutic Potential in Oncology. Interleukin 12: Antitumor Activity and Immunotherapeutic Potential in Oncology 21 41 .
Howard L. Kaufman & Neal Dharmadhikari. 2016. Cancer Therapeutic Targets. Cancer Therapeutic Targets 1 15 .